NCT00502879View on ClinicalTrials.gov

Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male Subjects

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2007

Study Completion Date

August 31, 2007

Conditions
Healthy
Interventions
DRUG

Enbrel (etanercept)

Trial Locations (1)

100730

Beijing

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00502879 - Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male Subjects | Biotech Hunter | Biotech Hunter